These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16708908)

  • 1. [Basal homocysteine blood levels in patients with venous thromboembolic disease from a rural area of southern Extremadura, Spain].
    Calvo-Romero JM; Lima-Rodríguez EM
    Rev Invest Clin; 2005; 57(6):820-1. PubMed ID: 16708908
    [No Abstract]   [Full Text] [Related]  

  • 2. Moderate hyperhomocysteinemia is a highly prevalent defect in Spanish patients with venous thromboembolic disease.
    González Y; Souto JC; Mateo J; Córdoba A; Blanco-Vaca F; Fontcuberta J
    Haematologica; 1998 Dec; 83(12):1126-7. PubMed ID: 9949633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects.
    Vayá A; Gómez I; Mira Y; Ferrando F; Corella D
    Thromb Haemost; 2008 Jun; 99(6):1132-4. PubMed ID: 18521525
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperhomocysteinaemia, hyperlipidaemia and risk of venous thromboembolism in Shiraz.
    Zamani A; Omrani GR; Lankarani KB
    East Mediterr Health J; 2003; 9(5-6):935-43. PubMed ID: 16450523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia in Spanish patients: more information.
    Vargas M; Soto I; Pinto CR; Urgelles MF
    Haematologica; 1999; 84(E-letters):E02. PubMed ID: 11084660
    [No Abstract]   [Full Text] [Related]  

  • 9. Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects.
    Mäkelburg AB; Lijfering WM; Middeldorp S; Hamulyák K; Veeger NJ; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):209-12. PubMed ID: 19132211
    [No Abstract]   [Full Text] [Related]  

  • 10. Are B vitamins a risk factor for VTE? Perhaps.
    den Heijer M
    J Thromb Haemost; 2006 Feb; 4(2):309-11. PubMed ID: 16420556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating P-selectin and the risk of recurrent venous thromboembolism.
    Kyrle PA; Hron G; Eichinger S; Wagner O
    Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.
    Lijfering WM; Coppens M; van de Poel MH; Middeldorp S; Hamulyák K; Bank I; Veeger NJ; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2007 Aug; 98(2):457-63. PubMed ID: 17721631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
    Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
    Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who is at risk for occult cancer after venous thromboembolism?
    Beckers MM; Schutgens RE; Prins MH; Biesma DH
    J Thromb Haemost; 2006 Dec; 4(12):2731-3. PubMed ID: 17002655
    [No Abstract]   [Full Text] [Related]  

  • 15. High-density lipoprotein and the risk of recurrent venous thromboembolism.
    Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH
    Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are B vitamins a risk factor for venous thromboembolism? Yes.
    Eichinger S
    J Thromb Haemost; 2006 Feb; 4(2):307-8. PubMed ID: 16420555
    [No Abstract]   [Full Text] [Related]  

  • 17. Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
    Nadar S; Blann A; Lip GY
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):513-4. PubMed ID: 12851541
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperhomocysteinemia and venous thrombosis.
    Gatt A; Makris M
    Semin Hematol; 2007 Apr; 44(2):70-6. PubMed ID: 17433898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
    Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
    J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticardiolipin antibodies in patients with venous thromboembolic disease from a Spanish rural area.
    Clin Appl Thromb Hemost; 2009; 15(2):247-8. PubMed ID: 19088097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.